# Daily Learning Brief

Generated on 2026-06-26 at 05:15 PDT. This is a downstream synthesis job; no new ingestion was run for this brief.

## 1. Date and Scope Reviewed

Scope reviewed: roughly 2026-06-25 21:52 PDT through 2026-06-26 05:15 PDT, anchored to the previous automation run and the current working tree. Evidence came from `git log --since='2026-06-25T04:52:13Z'`, scoped `git status` / `git diff`, `knowledge-base/meta/log.md`, `knowledge-base/meta/activity.md`, `knowledge-base/meta/gate-report.json`, June 26 video digest manifests, recent source and insight files, and AgentRun traces under `knowledge-base/runs/`.

Important boundary: routine names were not treated as proof. I counted a run as learned only where local traces showed source selection, extraction, and verification state. Active or blocked runs are explicitly labeled as such.

## 2. Executive Summary

- The strongest update is that agent value is moving from "can it produce a plausible change?" to "can the harness detect silent negative changes before expensive validation?" NOVA made this concrete with local pass rate, silent failure rate, and effective pass rate.
- The June 26 video digest added a broad agent/product/startup batch, but its durable synthesis is not "more agent enthusiasm." It reinforces that memory, specs, protocol design, security gates, and deterministic tools are the compounding layer.
- The DORA contradiction scout weakens any broad headcount-collapse or pure-speed belief. AI appears to amplify organizational health and delivery substrate; it does not erase coordination, trust, platform, or stability costs.
- Healthcare AI evidence became more calibrated: workflow support can improve documentation and treatment planning without yet proving patient-outcome lift. Clinical and agent evals both need process metrics plus final outcome metrics.
- Automation state is mixed: paper and video digest runs passed; the clinical AI x industry run extracted useful insights but is blocked because `learn` did not complete; the DORA contradiction scout is still active even though its insight patch is committed.

## 3. Sources Processed

- Daily AI paper digest: `RUN-260626-3721` selected arXiv:2606.27243, ingested `SRC-260626-7A5B` ("NOVA: A Verification-Aware Agent Harness for Architecture Evolution in Industrial Recommender Systems"), extracted 8 insights, and committed `07ca6c8a9c`.
- Daily AI video digest: `RUN-260626-89C8` processed 20 YouTube URLs from `knowledge-base/meta/daily-ai-video-digest-2026-06-26.txt`, wrote source IDs in `knowledge-base/meta/daily-ai-video-digest-2026-06-26-sources.txt`, extracted 100 attributed insights, repaired nested topic paths, and committed `4ab56f1c0a`, `d4463be297`, and `ef010c4460`.
- Daily AI x industry digest: `RUN-260626-B946` selected a Nature Medicine / EurekAlert clinical decision-support trial, ingested `SRC-260626-8708`, extracted 7 insights, passed health/reindex/embed/changed-gate, but closed `blocked` because `npm run learn` did not complete. Treat the insights as local/committed evidence with an incomplete post-ingest run, not a fully passed automation.
- Daily contradiction scout: `RUN-260626-5564` targeted `INS-260322-1D52` against Google Cloud's DORA 2025 report, ingested `SRC-260626-853D`, extracted 5 insights, and committed `9447768dc3`. The AgentRun remains `active`, so the belief update is useful but the automation state is incomplete.
- Prior late evidence still inside the 24-hour window: `RUN-260625-1E1D` Flex-Cat catalysis, `RUN-260625-AEC2` METR productivity RCT, and June 25 late video / benchmark-watch commits remain relevant context but were already synthesized in the previous brief.

## 4. Top Durable Insights

- Runnable is not enough. NOVA's central contribution is separating locally valid changes from production-effective changes; silent failures are the gap where code runs but semantics or business metrics degrade.
- Agent evals should decompose failure modes. A single pass rate hides whether the problem is invalid code, valid-but-useless code, weak verifier coverage, or poor online impact.
- Verification should be a cascade. Cheap semantic gates and local executability checks should prune candidates before offline training, human review, or online A/B tests.
- Failed attempts should become negative knowledge. NOVA's trajectory memory turns rejected modification patterns into forbidden directions for the next search step; this is directly relevant to AgentRun and Zuhn's own automation traces.
- The stable-memory / run-memory split matters. Durable KB principles and volatile per-run diagnostics should not be collapsed into one store; otherwise long-term memory gets polluted or active runs lose exact evidence.
- AI video-derived learning continues to converge on "harness over model." New June 26 insights cluster around agent-readable specs, protocol contracts, tool documentation as GTM, security boundaries, deterministic tooling, and customer/domain insight as the moat.
- DORA adds organizational counterevidence to AI-speed maximalism. AI-assisted delivery can raise throughput while worsening stability if the platform, tests, feedback loops, and team health are weak.
- Clinical AI reinforces the proxy/outcome split. AI Consult improved documentation and treatment planning, but the primary 14-day treatment-failure outcome did not significantly improve, so claims should stay bounded to workflow, safety, and cost signals.

## 5. Belief Updates

- Stronger: "Useful autonomy is capped by verifier quality." NOVA, video-derived harness patterns, and clinical evidence all point to domain-specific gates as the limiting substrate.
- Stronger: "AgentRun should preserve per-run trajectory evidence separately from long-term beliefs." Today's paper directly supports this architecture.
- Stronger: "AI adoption is systems change, not procurement." DORA's internal-platform and team-health findings strengthen the view that organizational substrate determines whether AI acceleration compounds or destabilizes.
- Weaker: "AI broadly collapses headcount and durable leads by itself." DORA is counterevidence: capital, models, and tools do not dissolve coordination and stability bottlenecks without platform quality and safety nets.
- More precise: "Clinical AI works first as workflow-embedded decision support." The credible near-term claim is improved documentation, planning, guideline adherence, and cost behavior, not proven patient-outcome transformation.
- Active tension: video digest evidence still supports aggressive agent-native product building, while DORA/METR/clinical evidence says the productivity and outcome claims must be observed at the final system boundary.

## 6. Actionable Implications

- For Zuhn: add a first-class state distinction in briefs and dashboards: passed/committed, committed-but-active, extracted-but-blocked, and stale. Today has all four, and flattening them would overstate evidence quality.
- For AgentRun: store silent-failure diagnostics and rejected directions as structured artifacts, not just narrative notes. Future runs should be able to say "do not retry this class of patch."
- For coding workflow: evaluate AI coding by final accepted change, review burden, stability, and incident risk, not elapsed typing time or self-reported speed.
- For product strategy: prefer products that become the control layer around deterministic tools, protocols, specs, and feedback loops. Model access alone is becoming the least durable part of the stack.
- For investing: discount AI productivity stories unless the company shows platform quality, feedback loops, stability metrics, and organizational adoption depth.
- For healthcare/vertical AI: position around measured workflow and cost improvements until patient-outcome evidence exists; do not market proxy gains as clinical transformation.
- For future digests: close or update active AgentRuns promptly. `RUN-260626-5564` and old `RUN-260625-A5DA` should not remain ambiguous after their useful evidence has been committed or superseded.

## 7. Open Questions and Verification Gaps

- `RUN-260626-5564` remains `active` despite committed DORA-derived insights. It needs final gates or closure before being counted as a passed contradiction scout.
- `RUN-260626-B946` is explicitly `blocked`: source ingestion and insight extraction succeeded, but `learn` did not complete.
- `knowledge-base/meta/activity.md` remains stale relative to June 25 and June 26 automation activity.
- `knowledge-base/meta/gate-report.json` still appears dated 2026-06-11, so it is not current proof for today's KB quality.
- The repo is ahead of `origin/main` and contains a broad dirty KB tree. This brief should be committed narrowly if changed, without sweeping unrelated knowledge-base edits.
- Video digest source manifests prove the 20 selected URLs and source IDs, but the brief does not individually audit all 100 video-derived insights; it samples representative clusters and relies on `RUN-260626-89C8` verification gates.

## 8. Links to Changed Files, Commits, and AgentRun IDs

- Visible brief: `knowledge-base/views/daily-learning-brief.md`
- Archive copy: `knowledge-base/meta/daily-learning-briefs/2026-06-26.md`
- This synthesis run: `knowledge-base/runs/RUN-260626-27F9.json`
- AgentRun traces reviewed: `RUN-260626-3721`, `RUN-260626-89C8`, `RUN-260626-B946`, `RUN-260626-5564`, `RUN-260625-1E1D`, `RUN-260625-AEC2`, `RUN-260625-5D34`, `RUN-260625-88AB`
- Key commits reviewed: `07ca6c8a9c`, `4ab56f1c0a`, `d4463be297`, `ef010c4460`, `9447768dc3`, plus prior-window commits `9036e90f4d`, `2f16c9d22c`, `da219ced3d`, and `3430434479`
- Representative sources: `knowledge-base/sources/blog/nova-a-verification-aware-agent-harness-for-architecture-evolution-in-industrial.md`, `knowledge-base/sources/blog/ai-support-tool-improved-clinician-decisions-in-real-world-primary-care-trial.md`, `knowledge-base/sources/blog/announcing-the-2025-dora-report.md`
- Representative insight files: `knowledge-base/domains/ai-development/agent-evals/evaluate-agent-harnesses-with-local-pass-rate-silent-failure-rate-and-effective.md`, `knowledge-base/domains/ai-development/agent-evals/runnable-code-is-an-insufficient-success-criterion-for-domain-changing-agents.md`, `knowledge-base/domains/ai-development/system-building/verification-cascades-should-order-checks-from-cheapest-semantic-blockers-to-exp.md`, `knowledge-base/domains/ai-development/system-building/agent-memory-should-distinguish-stable-knowledge-bases-from-run-local-trajectory.md`, `knowledge-base/domains/ai-development/ai-market-dynamics/ai-amplifies-organizational-health-instead-of-replacing-it.md`, `knowledge-base/domains/health/biotechnology/clinical-ai-value-must-be-proven-on-patient-outcomes-not-simulated-reasoning.md`
